HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

tandutinib

inhibits platelet-derived growth factor receptor tyrosine kinase; structure in first source
Also Known As:
4-(6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl)piperazine-1-carboxylic acid (4-isopropoxyphenyl)amide; CT 53518; CT-53518; CT53518; MLN 518; MLN-518; MLN518
Networked: 20 relevant articles (3 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Heinrich, Michael C: 3 articles (08/2009 - 11/2004)
2. Al-Shakliah, Nasser S: 2 articles (01/2021 - 01/2020)
3. Attwa, Mohamed W: 2 articles (01/2021 - 01/2020)
4. Kadi, Adnan A: 2 articles (01/2021 - 01/2020)
5. Druker, Brian J: 2 articles (12/2006 - 11/2004)
6. AlRabiah, Haitham: 1 article (01/2021)
7. Abdelhameed, Ali S: 1 article (01/2020)
8. Batchelor, Tracy T: 1 article (01/2017)
9. Chowdhary, Sajeel: 1 article (01/2017)
10. Desideri, Serena: 1 article (01/2017)

Related Diseases

1. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
2. Neoplasms (Cancer)
3. Leukemia
4. Glioblastoma (Glioblastoma Multiforme)
5. Renal Cell Carcinoma (Grawitz Tumor)

Related Drugs and Biologics

1. Sunitinib (Sutent)
2. 70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)
3. Transferases
4. Interleukin-2 (IL2)
5. Gemtuzumab (Mylotarg)
6. midostaurin
7. tandutinib
8. Phosphotransferases (Kinase)
9. tyrosine receptor (receptor, tyrosine)
10. Tyrosine Kinase Inhibitors

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Highly Active Antiretroviral Therapy (HAART)
4. Oral Administration